We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTU
1476
DELISTED
Virtusa Corporation
VRTU
$422K ﹤0.01%
12,986
– –
RPAY icon
1477
Repay Holdings
RPAY
$317M
$422K ﹤0.01%
+17,119
New +$345K
SYBT icon
1478
Stock Yards Bancorp
SYBT
$2.64B
$422K ﹤0.01%
10,488
+2,356
+29% +$76.8K
FARO
1479
DELISTED
Faro Technologies
FARO
$420K ﹤0.01%
7,841
– –
OSPN icon
1480
OneSpan
OSPN
$624M
$420K ﹤0.01%
15,031
– –
NTLA icon
1481
Intellia Therapeutics
NTLA
$1.66B
$419K ﹤0.01%
19,943
+4,202
+27% +$71.4K
TMP icon
1482
Tompkins Financial
TMP
$1.45B
$419K ﹤0.01%
6,467
+629
+11% +$41K
KTB icon
1483
Kontoor Brands
KTB
$4.65B
$418K ﹤0.01%
23,462
+3,412
+17% +$60.8K
MDGL icon
1484
Madrigal Pharmaceuticals
MDGL
$11.7B
$418K ﹤0.01%
3,687
– –
ENTA icon
1485
Enanta Pharmaceuticals
ENTA
$391M
$416K ﹤0.01%
8,294
– –
COOP
1486
DELISTED
Mr. Cooper
COOP
$416K ﹤0.01%
33,464
– –
AROC icon
1487
Archrock
AROC
$5.85B
$414K ﹤0.01%
63,856
– –
NXRT
1488
NexPoint Residential Trust
NXRT
$636M
$413K ﹤0.01%
11,670
+2,516
+27% +$77.9K
USNA icon
1489
Usana Health Sciences
USNA
$252M
$411K ﹤0.01%
5,595
– –
MHO icon
1490
M/I Homes
MHO
$3.9B
$409K ﹤0.01%
11,887
– –
AMPH icon
1491
Amphastar Pharmaceuticals
AMPH
$858M
$409K ﹤0.01%
18,205
– –
RAD
1492
DELISTED
Rite Aid Corporation
RAD
$409K ﹤0.01%
23,960
– –
TBIO
1493
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$408K ﹤0.01%
22,789
+6,603
+41% +$99.6K
ALEX
1494
DELISTED
Alexander & Baldwin
ALEX
$407K ﹤0.01%
33,353
+3,736
+13% +$44.1K
SWTX
1495
DELISTED
SpringWorks Therapeutics
SWTX
$405K ﹤0.01%
9,640
+4,653
+93% +$166K
REGI
1496
DELISTED
Renewable Energy Group, Inc.
REGI
$404K ﹤0.01%
16,294
– –
BRSL
1497
Brightstar Lottery PLC
BRSL
$2.15B
$403K ﹤0.01%
+45,302
New +$353K
PFS icon
1498
Provident Financial Services
PFS
$3.26B
$403K ﹤0.01%
27,899
– –
AZZ icon
1499
AZZ Inc
AZZ
$4.52B
$402K ﹤0.01%
11,705
– –
PGTI
1500
DELISTED
PGT, Inc.
PGTI
$401K ﹤0.01%
25,605
– –
58 59
60
61 62

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.